Hepion Pharmaceuticals, Inc. 4 Filing
Ticker: HEPA · Form: 4 · Filed: Apr 27, 2026 · CIK: 0001583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (HEPA) |
| Form Type | 4 |
| Filed Date | Apr 27, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 4 filing submitted by Hepion Pharmaceuticals, Inc. (ticker: HEPA) to the SEC on Apr 27, 2026.
Where can I view the full 4 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 27, 2026 regarding Hepion Pharmaceuticals, Inc. (HEPA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.